文献速递认知障碍与痴呆

慢性疼痛与脑脊液中神经退行性变、小胶质细胞激活及炎症生物标志物的关联及认知功能受损

Association of Chronic Pain with Biomarkers of Neurodegeneration, Microglial Activation, and Inflammation in Cerebrospinal Fluid and Impaired Cognitive Function.
PubMed 文献 · Ann Neurol · 2023-10-12

本研究基于阿尔茨海默病神经影像学倡议数据,将995名参与者按ATN分类,其中605人(60.81%)在基线报告慢性疼痛。分析发现,在疑似非阿尔茨海默病病理生理组中,慢性疼痛与脑脊液t-tau和sTREM2水平升高相关;慢性疼痛与肿瘤坏死因子α水平升高相关,与ATN分组无关。纵向观察中,淀粉样蛋白和神经退行性变标志物阴性的慢性疼痛患者脑脊液ptau181水平升高,但任何ATN组均未观察到认知功能显著纵向下降。

要点

  • 在疑似非阿尔茨海默病病理生理组中,慢性疼痛与脑脊液t-tau和sTREM2水平升高相关。
  • 慢性疼痛与肿瘤坏死因子α水平升高相关,且不依赖于ATN分组。
  • 淀粉样蛋白和神经退行性变标志物阴性的慢性疼痛患者,其脑脊液ptau181水平纵向升高。

核心结论

  • 本研究提示慢性疼痛在阿尔茨海默病谱系的特定亚组患者中诱导神经元损伤和小胶质细胞激活。
  • 需要进一步研究以确认这些发现。

研究设计与样本

  • 研究使用阿尔茨海默病神经影像学倡议的数据,共纳入995名参与者。
  • 参与者根据ATN(淀粉样蛋白、tau、神经退行性变)分类法进行分类。
  • 慢性疼痛定义为基线时报告的持续性或复发性疼痛。

主要发现

  • 基线时,疑似非阿尔茨海默病病理生理组中,慢性疼痛患者脑脊液t-tau和sTREM2水平升高。
  • 慢性疼痛与肿瘤坏死因子α水平升高相关, irrespective of ATN组。
  • 纵向观察中,淀粉样蛋白和神经退行性变标志物阴性的慢性疼痛患者脑脊液ptau181水平升高。
  • 淀粉样蛋白阳性且神经退行性变阴性的慢性疼痛患者,横断面记忆功能更高。
  • 任何ATN组均未观察到认知功能的显著纵向下降。

局限性

  • 需要进一步研究以确认这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Debate surrounds the role of chronic pain as a risk factor for cognitive decline and dementia. This study aimed at examining the association of chronic pain with biomarkers of neurodegeneration using data from the Alzheimer's Disease Neuroimaging Initiative. METHODS: Participants were classified using the ATN (amyloid, tau, neurodegeneration) classification. Chronic pain was defined as persistent or recurrent pain reported at baseline. For each ATN group, analysis of covariance models identified differences in cerebrospinal fluid (CSF) levels of amyloid β1-42, phosphorylated tau 181 (ptau181), total tau (t-tau), soluble triggering receptor expressed on myeloid cells 2 (sTREM2), and cognitive function between chronic pain states. Differences in CSF levels of inflammatory markers between chronic pain states were further analyzed. Linear mixed effect models examined longitudinal changes. RESULTS: The study included 995 individuals, with 605 (60.81%) reporting chronic pain at baseline. At baseline, individuals with suspected non-Alzheimer pathophysiology and chronic pain showed increased CSF levels of t-tau and sTREM2. Chronic pain was associated with increased tumor necrosis factor α levels, irrespective of the ATN group. Longitudinally, an increase in ptau181 CSF levels was observed in chronic pain patients with negative amyloid and neurodegeneration markers. Amyloid-positive and neurodegeneration-negative chronic pain patients showed higher memory function cross-sectionally. No significant longitudinal decline in cognitive function was observed for any ATN group. INTERPRETATION: Our study suggests that chronic pain induces neuronal damage and microglial activation in particular subgroups of patients along the AD spectrum. Further studies are needed to confirm these findings. ANN NEUROL 2024;95:195-206.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Sadlon A, Takousis P, Ankli B, et al. Association of Chronic Pain with Biomarkers of Neurodegeneration, Microglial Activation, and Inflammation in Cerebrospinal Fluid and Impaired Cognitive Function. Ann Neurol. 2023. PMID: 37787094. doi:10.1002/ana.26804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。